|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2003-5-29
|
|
pubmed:abstractText |
The T-20 vs. Optimized Regimen Only Study 2 (TORO 2) compared the efficacy and safety of 24 weeks of treatment with the fusion inhibitor enfuvirtide in combination with an optimized background antiretroviral regimen with the efficacy and safety of the optimized background regimen alone.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:ArastéhKeikawusK,
pubmed-author:ClotetBonaventuraB,
pubmed-author:CooperDavidD,
pubmed-author:DeMasiRalphR,
pubmed-author:DelehantyJohnJ,
pubmed-author:DelfraissyJean-FrançoisJF,
pubmed-author:DrobnesClaudeC,
pubmed-author:HusonLesL,
pubmed-author:KatlamaChristineC,
pubmed-author:LangeJoepJ,
pubmed-author:LazzarinAdrianoA,
pubmed-author:NelsonMarkM,
pubmed-author:ReynesJacquesJ,
pubmed-author:SalgoMiklosM,
pubmed-author:StellbrinkHans-JürgenHJ,
pubmed-author:TORO 2 Study Group,
pubmed-author:WatCynthiaC
|
|
pubmed:copyrightInfo |
Copyright 2003 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
29
|
|
pubmed:volume |
348
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2186-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12773645-Adult,
pubmed-meshheading:12773645-Anti-HIV Agents,
pubmed-meshheading:12773645-Australia,
pubmed-meshheading:12773645-CD4 Lymphocyte Count,
pubmed-meshheading:12773645-Drug Resistance, Viral,
pubmed-meshheading:12773645-Drug Therapy, Combination,
pubmed-meshheading:12773645-Europe,
pubmed-meshheading:12773645-Female,
pubmed-meshheading:12773645-HIV Envelope Protein gp41,
pubmed-meshheading:12773645-HIV Fusion Inhibitors,
pubmed-meshheading:12773645-HIV Infections,
pubmed-meshheading:12773645-HIV-1,
pubmed-meshheading:12773645-Humans,
pubmed-meshheading:12773645-Injections, Subcutaneous,
pubmed-meshheading:12773645-Male,
pubmed-meshheading:12773645-Patient Compliance,
pubmed-meshheading:12773645-Peptide Fragments,
pubmed-meshheading:12773645-RNA, Viral
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.
|
|
pubmed:affiliation |
Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Vita-Salute University, Milan, Italy. lazzarin.adriano@hsr.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
